These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency]. De Pergola E, Di Lorenzo L, De Pergola G. G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986 [No Abstract] [Full Text] [Related]
5. Effect of two years' Cavinton treatment on the ECG. Farsang C, Kertész G, Bánki MC, Juvancz P. Ther Hung; 1987 Aug; 35(3):125-8. PubMed ID: 3438872 [No Abstract] [Full Text] [Related]
6. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. Balestreri R, Fontana L, Astengo F. J Am Geriatr Soc; 1987 May; 35(5):425-30. PubMed ID: 3553281 [Abstract] [Full Text] [Related]
7. Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders. Jansen W, O'Connolly M, Lehmann E, Mayer M. Pharmacopsychiatry; 1986 Sep; 19(5):389-94. PubMed ID: 3534902 [Abstract] [Full Text] [Related]
10. [Use of cavinton in neuropaediatrics]. Studenikin VM. Zh Nevrol Psikhiatr Im S S Korsakova; 2004 Sep; 104(12):63-4. PubMed ID: 15847328 [No Abstract] [Full Text] [Related]
11. [Treatment of circulatory encephalopathy with Cavinton]. Lebedeva NV, Chukhrova VA, Solov'ev OU, Nepesov RR. Klin Med (Mosk); 1997 Sep; 75(11):51-3. PubMed ID: 9490359 [No Abstract] [Full Text] [Related]
12. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies]. Burtsev EM, Shprakh VV, Savkov VS. Ross Med Zh; 1992 Sep; (2):41-3. PubMed ID: 1643337 [No Abstract] [Full Text] [Related]
13. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine]. Tamaki N, Matsumoto S. Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571 [No Abstract] [Full Text] [Related]
14. Cavinton, a new cerebral vasodilator. Solti F. Ther Hung; 1979 Feb; 27(1):15-6. PubMed ID: 494137 [No Abstract] [Full Text] [Related]
15. [Trial of using Cavinton in cerebrovascular disorders]. Shtok VN, Eremeeva SV. Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560 [No Abstract] [Full Text] [Related]
16. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug]. Cucinotta D, Monica C, Silvestrini C, Ceccato S, Cocchi C. G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589 [No Abstract] [Full Text] [Related]
17. Effect of vinpocetine on red blood cell deformability in stroke patients. Hayakawa M. Arzneimittelforschung; 1992 Apr; 42(4):425-7. PubMed ID: 1642666 [Abstract] [Full Text] [Related]
18. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Osawa M, Maruyama S. Ther Hung; 1985 Apr; 33(1):7-12. PubMed ID: 3842000 [No Abstract] [Full Text] [Related]
19. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases]. Kauchtschischvili G, Nappi G, Bono G. Minerva Med; 1974 May 26; 65(40):2296-315. PubMed ID: 4608671 [No Abstract] [Full Text] [Related]
20. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients]. Fidetzis K, Brosteano R, Keller P. Med Welt; 1976 Jul 16; 27(29):1412-4. PubMed ID: 785150 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]